Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Gynecology

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    January 2012
  1. WANG KL , Chang TC, Jung SM, Chen CH, et al
    Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group study.
    Eur J Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. VAN GORP T , Veldman J, Van Calster B, Cadron I, et al
    Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
    Eur J Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  3. NOUT RA , Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, et al
    Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  4. KNAPPSKOG S , Trovik J, Marcickiewicz J, Tingulstad S, et al
    SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  5. CROSBIE EJ , Roberts C, Qian W, Swart AM, et al
    Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. CAROZZI F , Ronco G, Gillio-Tos A, Marco LD, et al
    Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  7. BAMIAS A , Sotiropoulou M, Zagouri F, Trachana P, et al
    Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  8. ATTIAS-GEVA Z , Bentov I, Kidron D, Amichay K, et al
    p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. WOELBER L , Kock L, Gieseking F, Petersen C, et al
    Clinical management of primary vulvar cancer.
    Eur J Cancer. 2011;47:2315-21.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  10. VERGOTE I , Amant F, Kristensen G, Ehlen T, et al
    Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Eur J Cancer. 2011;47 Suppl 3:S88-92.
    PubMed     Text format     Related articles    Abstract available



  11. PAVLIDIS N
    Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer?
    Eur J Cancer. 2011;47 Suppl 3:S348-52.
    PubMed     Text format     Related articles    Abstract available



  12. CASALI PG , Sanfilippo R
    Uterine sarcomas: a multidisciplinary challenge.
    Eur J Cancer. 2011;47 Suppl 3:S326-7.
    PubMed     Text format     Related articles   



  13. BANERJEE S , Kaye S
    The role of targeted therapy in ovarian cancer.
    Eur J Cancer. 2011;47 Suppl 3:S116-30.
    PubMed     Text format     Related articles    Abstract available



  14. LEDERMANN JA , Raja FA
    Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer.
    Eur J Cancer. 2011;47 Suppl 3:S104-15.
    PubMed     Text format     Related articles    Abstract available



  15. VERGOTE I
    Chairperson's introduction: Surgical skills, especially in the upper abdomen, remain pivotal in the treatment of advanced ovarian cancer.
    Eur J Cancer. 2011;47 Suppl 3:S86-7.
    PubMed     Text format     Related articles   



  16. WINTHER JF , Olsen JH
    Adverse reproductive effects of treatment for cancer in childhood and adolescence.
    Eur J Cancer. 2011;47 Suppl 3:S230-8.
    PubMed     Text format     Related articles   



  17. NOBILE A , Treboux A, Delaloye JF, Zaman K, et al
    What makes a good pathology report?
    Eur J Cancer. 2011;47:2082-3.
    PubMed     Text format     Related articles   



    August 2011
  18. REINARTZ S , Failer S, Schuell T, Wagner U, et al
    CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  19. BRAICU EI , Sehouli J, Richter R, Pietzner K, et al
    Primary versus secondary cytoreduction for epithelial ovarian cancer: A paired analysis of tumour pattern and surgical outcome.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  20. RAPITI E , Usel M, Neyroud-Caspar I, Merglen A, et al
    Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  21. BIJEN CB , de Bock GH, Vermeulen KM, Arts HJ, et al
    Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obese.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. LI BH , Zhou JS, Ye F, Cheng XD, et al
    Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. KING J , Wynne CH, Assersohn L, Jones A, et al
    Hormone replacement therapy and women with premature menopause - A cancer survivorship issue.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  24. BOLL D , Verhoeven RH, van der Aa MA, Lybeert ML, et al
    Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles   



  25. YIGIT R , Figdor CG, Zusterzeel PL, Pots JM, et al
    Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles   



  26. SROCZYNSKI G , Schnell-Inderst P, Muhlberger N, Lang K, et al
    Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysis.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  27. KITCHENER HC , Gilham C, Sargent A, Bailey A, et al
    A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial.
    Eur J Cancer. 2011;47:864-71.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  28. ATTIAS-GEVA Z , Bentov I, Ludwig DL, Fishman A, et al
    Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. YU H , Su J, Xu Y, Kang J, et al
    p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  30. LANGBALLE R , Olsen JH, Andersson M, Mellemkjaer L, et al
    Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  31. FARATIAN D , Um I, Wilson DS, Mullen P, et al
    Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  32. SHAPIRO CL , Halabi S, Hars V, Archer L, et al
    Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  33. SUNDBERG KK , Lampic C, Arvidson J, Helstrom L, et al
    Sexual function and experience among long-term survivors of childhood cancer.
    Eur J Cancer. 2011;47:397-403.
    PubMed     Text format     Related articles    Abstract available



  34. DE KOK IM , Habbema JD, van Rosmalen J, van Ballegooijen M, et al
    Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?
    Eur J Cancer. 2011;47:428-35.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  35. GANZINELLI M , Mariani P, Cattaneo D, Fossati R, et al
    Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. REBOLJ M , Pribac I, Lynge E
    False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition.
    Eur J Cancer. 2011;47:255-61.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  37. ZHAN P , Suo LJ, Qian Q, Shen XK, et al
    Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  38. DIAZ M , de Sanjose S, Ortendahl J, O'Shea M, et al
    Cost-effectiveness of human papillomavirus vaccination and screening in Spain.
    Eur J Cancer. 2010;46:2973-85.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: